These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
224 related items for PubMed ID: 35278193
1. Brivaracetam Modulates Short-Term Synaptic Activity and Low-Frequency Spontaneous Brain Activity by Delaying Synaptic Vesicle Recycling in Two Distinct Rodent Models of Epileptic Seizures. Xing H, Han X, Xu S, Sun Z, Yang S. J Mol Neurosci; 2022 May; 72(5):1058-1074. PubMed ID: 35278193 [Abstract] [Full Text] [Related]
2. Brivaracetam augments short-term depression and slows vesicle recycling. Yang X, Bognar J, He T, Mohammed M, Niespodziany I, Wolff C, Esguerra M, Rothman SM, Dubinsky JM. Epilepsia; 2015 Dec; 56(12):1899-909. PubMed ID: 26515103 [Abstract] [Full Text] [Related]
3. Brivaracetam Prevents the Over-expression of Synaptic Vesicle Protein 2A and Rescues the Deficits of Hippocampal Long-term Potentiation In Vivo in Chronic Temporal Lobe Epilepsy Rats. Ge YX, Lin YY, Bi QQ, Chen YJ. Curr Neurovasc Res; 2020 Dec; 17(4):354-360. PubMed ID: 32407277 [Abstract] [Full Text] [Related]
7. Adjunctive brivaracetam in adults with uncontrolled focal epilepsy: results from a double-blind, randomized, placebo-controlled trial. Ryvlin P, Werhahn KJ, Blaszczyk B, Johnson ME, Lu S. Epilepsia; 2014 Jan; 55(1):47-56. PubMed ID: 24256083 [Abstract] [Full Text] [Related]
8. Brivaracetam: review of its pharmacology and potential use as adjunctive therapy in patients with partial onset seizures. Mumoli L, Palleria C, Gasparini S, Citraro R, Labate A, Ferlazzo E, Gambardella A, De Sarro G, Russo E. Drug Des Devel Ther; 2015 Jan; 9():5719-25. PubMed ID: 26543353 [Abstract] [Full Text] [Related]
10. Favorable adverse effect profile of brivaracetam vs levetiracetam in a preclinical model. Sanon NT, Gagné J, Wolf DC, Aboulamer S, Bosoi CM, Simard A, Messiet E, Desgent S, Carmant L. Epilepsy Behav; 2018 Feb; 79():117-125. PubMed ID: 29287214 [Abstract] [Full Text] [Related]
12. Acute and long-term effects of brivaracetam and brivaracetam-diazepam combinations in an experimental model of status epilepticus. Niquet J, Suchomelova L, Thompson K, Klitgaard H, Matagne A, Wasterlain C. Epilepsia; 2017 Jul; 58(7):1199-1207. PubMed ID: 28597912 [Abstract] [Full Text] [Related]
18. Brivaracetam does not modulate ionotropic channels activated by glutamate, γ-aminobutyric acid, and glycine in hippocampal neurons. Niespodziany I, Rigo JM, Moonen G, Matagne A, Klitgaard H, Wolff C. Epilepsia; 2017 Nov; 58(11):e157-e161. PubMed ID: 28850675 [Abstract] [Full Text] [Related]
20. Brivaracetam as add-on therapy in children with developmental epileptic encephalopathies: A study of 42 patients. Caraballo RH, Reyes G, Chacón S, Fortini PS. Epilepsy Behav; 2024 Jan; 150():109561. PubMed ID: 38070405 [Abstract] [Full Text] [Related] Page: [Next] [New Search]